RHEI LIFE DOO
About
Company description
WHO WE ARE
Founded in 2015 in Serbia and the United Arab Emirates, Rhei
Life was established with a clear vision: to become a relevant and reliable
stakeholder in the global healthcare landscape. The company initially focused
on the Adriatic region, followed by systematic expansion across Europe. Today,
Rhei Life is present and recognized on the global healthcare scene.
OUR BUSINESS MODEL
TWO STRATEGIC DIVISIONS – ONE CLEAR VISION
Rhei Life operates through two clearly defined and
complementary business divisions, both aligned with our long-term strategy and
global ambitions.
Products Development for Global Markets
Through continuous investments in research and development,
Rhei Life positions itself as a global healthcare stakeholder by developing
innovative products used by patients worldwide. Our portfolio includes
medicines, food supplements, and medical devices, developed either in-house or
through co-development models in collaboration with strategic partners.
Our products are commercialized globally through a trusted
network of partners and customers who have placed their confidence in Rhei Life
across all continents.
Today, Rhei Life is present in 49 countries, 5
continents with:
- 90 partner companies worldwide
- Launched products or signed commercial agreements
STRATEGIC PARTNERSHIPS
Trusted by Leading Global Pharmaceutical Companies
Rhei Life products are trusted by leading global pharmaceutical companies that have included our products in their portfolios across multiple therapeutic areas and markets worldwide.
These collaborations reflect long-term confidence in the quality, safety, scientific value, and commercial potential of Rhei Life products.
Our partners recognize Rhei Life as a reliable, long-term collaborator capable of delivering innovation, regulatory expertise, and commercial excellence.
SCIENTIFIC VALIDATION
Commitment to Clinical Evidence and Safety
Special attention is given to confirming product efficacy and safety through clinical studies conducted in accordance with international standards.
In addition to in-house development, selected products are developed in close cooperation with partners through co-development models.
MANUFACTURING & QUALITY
Our in-house developed products are manufactured in 11 different CMOs across Europe, fulfilling strict regulatory and quality requirements for global markets. Manufacturing standards meet the requirements of national regulatory authorities as well as the stringent quality expectations of multinational pharmaceutical companies successfully promoting our products in some of the world’s most regulated markets.
Quick facts
| Sales markets | Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Primary business activity | Manufacturer: Finished Food Products |
| Affiliated categories: | Citicoline |Collagen peptides |Glucosamine More |
